KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) Invested Capital: 2009-2024

Historic Invested Capital for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to $596.8 million.

  • Dynavax Technologies' Invested Capital fell 21.61% to $534.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $534.1 million, marking a year-over-year decrease of 21.61%. This contributed to the annual value of $596.8 million for FY2024, which is 4.06% down from last year.
  • According to the latest figures from FY2024, Dynavax Technologies' Invested Capital is $596.8 million, which was down 4.06% from $622.1 million recorded in FY2023.
  • Dynavax Technologies' 5-year Invested Capital high stood at $622.1 million for FY2023, and its period low was $58.7 million during FY2020.
  • For the 3-year period, Dynavax Technologies' Invested Capital averaged around $600.0 million, with its median value being $596.8 million (2024).
  • Its Invested Capital has fluctuated over the past 5 years, first spiked by 608.00% in 2020, then declined by 4.06% in 2024.
  • Dynavax Technologies' Invested Capital (Yearly) stood at $58.7 million in 2020, then spiked by 278.88% to $222.4 million in 2021, then surged by 161.28% to $581.0 million in 2022, then climbed by 7.07% to $622.1 million in 2023, then declined by 4.06% to $596.8 million in 2024.